Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Yagita

Showing results (1-10 of 448) with videos related to

Pageof 45
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 1, 1990
[MHC-restricted antigen recognition by T cells]H Yagita
Arerugi = [Allergy]|October 1, 1993
[Immunity and cell adhesion molecules]H Yagita
Journal of Biological Regulators and Homeostatic Agents|June 7, 2000
CD95LH Yagita
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1986
Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. II. Requisite role of the monoclonal antibody-defined antigen systems in activation and proliferation of human and rat lymphocytesH Yagita, Y Hashimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 1, 1992
[Progress and application of multiple-parameter flow cytometric analysis]H Matsuda, H Yagita
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 1, 1996
[Metalloproteinase-mediated release of human fas ligand]N Kayagaki, H Yagita
Springer Seminars in Immunopathology|April 16, 1998
Can expression of CD95 (Fas/APO-1) ligand on grafts or tumor cells prevent their rejection?J Allison, K Seino, H Yagita
Journal of the National Cancer Institute|March 1, 1984
Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cellsT Masuko, H Yagita, Y Hashimoto
Ryumachi. [Rheumatism]|April 1, 1994
[Cytotoxicity and apoptosis]K Okumura, S Hanabuchi, H Yagita
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1988
Molecular cloning of the murine homologue of CD2. Homology of the molecule to its human counterpart T11H Yagita, K Okumura, H Nakauchi
Pageof 45

Showing results (1-10 of 448) with videos related to

Sort By:
Pageof 45
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 1, 1990
[MHC-restricted antigen recognition by T cells]H Yagita
Arerugi = [Allergy]|October 1, 1993
[Immunity and cell adhesion molecules]H Yagita
Journal of Biological Regulators and Homeostatic Agents|June 7, 2000
CD95LH Yagita
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1986
Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. II. Requisite role of the monoclonal antibody-defined antigen systems in activation and proliferation of human and rat lymphocytesH Yagita, Y Hashimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 1, 1992
[Progress and application of multiple-parameter flow cytometric analysis]H Matsuda, H Yagita
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 1, 1996
[Metalloproteinase-mediated release of human fas ligand]N Kayagaki, H Yagita
Springer Seminars in Immunopathology|April 16, 1998
Can expression of CD95 (Fas/APO-1) ligand on grafts or tumor cells prevent their rejection?J Allison, K Seino, H Yagita
Journal of the National Cancer Institute|March 1, 1984
Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cellsT Masuko, H Yagita, Y Hashimoto
Ryumachi. [Rheumatism]|April 1, 1994
[Cytotoxicity and apoptosis]K Okumura, S Hanabuchi, H Yagita
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1988
Molecular cloning of the murine homologue of CD2. Homology of the molecule to its human counterpart T11H Yagita, K Okumura, H Nakauchi
Pageof 45